266 related articles for article (PubMed ID: 29796952)
1. Cardiac diagnostics before oral propranolol therapy in infantile hemangioma: retrospective evaluation of 234 infants.
Frongia G; Byeon JO; Arnold R; Mehrabi A; Günther P
World J Pediatr; 2018 Jun; 14(3):254-258. PubMed ID: 29796952
[TBL] [Abstract][Full Text] [Related]
2. Cardiac screening in infants with infantile hemangiomas before propranolol treatment.
Blei F; McElhinney DB; Guarini A; Presti S
Pediatr Dermatol; 2014; 31(4):465-70. PubMed ID: 24889812
[TBL] [Abstract][Full Text] [Related]
3. Patient Perspectives: Propranolol for infantile hemangiomas.
Pediatr Dermatol; 2016 Sep; 33(5):549-50. PubMed ID: 27595871
[No Abstract] [Full Text] [Related]
4. Is Routine Electrocardiography Necessary Before Initiation of Propranolol for Treatment of Infantile Hemangiomas?
Yarbrough KB; Tollefson MM; Krol AL; Leitenberger SL; Mann JA; MacArthur CJ
Pediatr Dermatol; 2016 Nov; 33(6):615-620. PubMed ID: 27599450
[TBL] [Abstract][Full Text] [Related]
5. Utility of routine electrocardiographic screening before initiation of propranolol for infantile hemangiomas.
Lund EB; Chamlin SL; Mancini AJ
Pediatr Dermatol; 2018 Jul; 35(4):e233-e234. PubMed ID: 29683225
[TBL] [Abstract][Full Text] [Related]
6. Beta blocker treatment for infantile hemangiomas.
Rouhana HF; Fruge JH; Massengale WT
Dermatol Online J; 2015 Jul; 21(7):. PubMed ID: 26436966
[TBL] [Abstract][Full Text] [Related]
7. Preliminary experiences in treating infantile hemangioma with propranolol.
Chai Q; Chen WL; Huang ZQ; Zhang DM; Fan S; Wang L
Ann Plast Surg; 2014 Feb; 72(2):169-72. PubMed ID: 21629056
[TBL] [Abstract][Full Text] [Related]
8. Clinical and Radiological Evaluation of Periocular Infantile Hemangioma Treated With Oral Propranolol: A Case Series.
Ginguerra MA; Saito O; Fernandes JBVD; Castro DS; Matayoshi S
Am J Ophthalmol; 2018 Jan; 185():48-55. PubMed ID: 29103963
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and safety of propranolol cream in infantile hemangioma: A prospective pilot study.
Nagata E; Kashiwagura Y; Okada E; Tanaka S; Sano S; Nishida M; Hayano S; Iwashima S; Hakamata A; Odagiri K; Inui N; Watanabe H; Umemura K; Uchida S
J Pharmacol Sci; 2022 Jun; 149(2):60-65. PubMed ID: 35512856
[TBL] [Abstract][Full Text] [Related]
10. Propranolol therapy in 55 infants with infantile hemangioma: dosage, duration, adverse effects, and outcome.
Schupp CJ; Kleber JB; Günther P; Holland-Cunz S
Pediatr Dermatol; 2011; 28(6):640-644. PubMed ID: 21995836
[TBL] [Abstract][Full Text] [Related]
11. Safety profile during initiation of propranolol for treatment of infantile haemangiomas in an ambulatory day-care hospitalization setting.
Fogel I; Ollech A; Zvulunov A; Valdman-Greenshpon Y; Atar Snir V; Friedland R; Lapidoth M; Ben-Amitai D
J Eur Acad Dermatol Venereol; 2018 Nov; 32(11):2004-2009. PubMed ID: 29573481
[TBL] [Abstract][Full Text] [Related]
12. Experience with Holter monitoring during propranolol therapy for infantile hemangiomas.
Jacks SK; Kertesz NJ; Witman PM; Fernandez Faith E
J Am Acad Dermatol; 2015 Aug; 73(2):255-7. PubMed ID: 26054433
[TBL] [Abstract][Full Text] [Related]
13. Propranolol in the management of infantile hemangiomas: clinical response and predictors.
Balma-Mena A; Chakkittakandiyil A; Weinstein M; Lansang P; Ho N; Cammisuli S; Pope E
J Cutan Med Surg; 2012; 16(3):169-73. PubMed ID: 22713439
[TBL] [Abstract][Full Text] [Related]
14. Reduction in astigmatism using propranolol as first-line therapy for periocular capillary hemangioma.
Fabian ID; Ben-Zion I; Samuel C; Spierer A
Am J Ophthalmol; 2011 Jan; 151(1):53-8. PubMed ID: 20970771
[TBL] [Abstract][Full Text] [Related]
15. Low-dose propranolol for infantile hemangioma of the head and neck: Analysis of 23 consecutive patients.
Ren W; Li S; Gao L; Huang S; Zhang L; Qiang C; Liu C; Zhi K
Pediatr Int; 2017 Feb; 59(2):213-217. PubMed ID: 27473874
[TBL] [Abstract][Full Text] [Related]
16. Is Propranolol Safe and Effective for Outpatient Use for Infantile Hemangioma? A Prospective Study of 679 Cases From One Center in China.
Chang L; Ye X; Qiu Y; Ma G; Jin Y; Chen H; Lv D; Yu W; Yang X; Wang T; Lin X
Ann Plast Surg; 2016 May; 76(5):559-63. PubMed ID: 26101993
[TBL] [Abstract][Full Text] [Related]
17. Oral Nadolol for Children with Infantile Hemangiomas and Sleep Disturbances with Oral Propranolol.
Bernabeu-Wittel J; Narváez-Moreno B; de la Torre-García JM; Fernández-Pineda I; Domínguez-Cruz JJ; Coserría-Sánchez F; Álvarez-del-Vayo C; Conejo-Mir J
Pediatr Dermatol; 2015; 32(6):853-7. PubMed ID: 26447831
[TBL] [Abstract][Full Text] [Related]
18. Outpatient use of oral propranolol and topical timolol for infantile hemangiomas: survey results and comparison with propranolol consensus statement guidelines.
Kumar MG; Coughlin C; Bayliss SJ
Pediatr Dermatol; 2015; 32(2):171-9. PubMed ID: 25556828
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonography as an objective tool for assessment of infantile hemangioma treatment with propranolol.
Rotter A; Samorano LP; de Oliveira Labinas GH; Alvarenga JG; Rivitti-Machado MC; Bouer M; Santos PC; Silvestre DA; de Oliveira ZN
Int J Dermatol; 2017 Feb; 56(2):190-194. PubMed ID: 27813086
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of periorbital infantile hemangiomas: Case series and literature review.
Sun LM; Xu Y; Xu MN; Wang M; Su Y; Yuan SM
Int J Pediatr Otorhinolaryngol; 2020 Sep; 136():110157. PubMed ID: 32544638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
